Integrins adhesion molecules and some of their ligands in laryngeal cancer

Experimental Oncology

Volumn 27, Issue 2, 2005, Pages 86-90

  Charalabopoulos, Konstantinos ^a   Mittari, Evanthia ^a   Karakosta, Agathi ^a   Golias, Christos ^a   Batistatou, Anna ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Adhesion molecules; Integrins; Laminin; Laryngeal cancer; Tenascin; Type IV collagen

Indexed keywords

ALPHA INTEGRIN; ALPHA6BETA4 INTEGRIN; BETA INTEGRIN; CELL ADHESION MOLECULE; COLLAGEN TYPE 4; CYTOKINE; FIBRONECTIN; HYDROXYICOSATETRAENOIC ACID; INTEGRIN; LAMININ; TENASCIN; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 3; VERY LATE ACTIVATION ANTIGEN 5; VERY LATE ACTIVATION ANTIGEN 6; VITRONECTIN;

CANCER RECURRENCE; CARCINOGENESIS; CELL MIGRATION; CELL STRUCTURE; CORRELATION ANALYSIS; CYTOARCHITECTURE; DIAGNOSTIC VALUE; HEAD AND NECK CANCER; HUMAN; IMMUNOREACTIVITY; LARYNX CANCER; LYMPH NODE METASTASIS; MALIGNANT TRANSFORMATION; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

ANIMALS; CELL ADHESION; EXTRACELLULAR MATRIX; HUMANS; INTEGRINS; LARYNGEAL NEOPLASMS; LIGANDS;

EID: 22644446081     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Eidelman GM, Crossin KL. Cell adhesion molecules: implications for a molecular histology. Ann Rev Biochem 1991; 60: 155-90.
2. Charalabopoulos K, Pignatelli M. Adhesion molecules and cancer. Arch Hell Med 2001; 18: 16-9.
3. Charalabopoulos K, Binolis J, Karkabounas S. Adhesion molecules in carcinogenesis. Exp Oncol 2002; 24: 249-57.
4. Charalabopoulos K, Papalimneou V, Charalabopoulos A. Adhesion molecules in lung cancer. Exp Oncol 2003; 25: 16-21.
5. Charalabopoulos K, Tsabalas S, Syrigos K, Giannakopoulos X, Kalfakakou V, Kiortsis D, Alamanos J, Charalabopoulos A, Evangelou A, Sofikitis N, Agnantis NJ. Correlation of E-cadherin expression with clinicopathological data in patients suffering from transitional cell carcinoma of the bladder. Exp Oncol 2003; 25: 180-5.
6. Hynes RQ. Integrins: versatility, modulation and signaling in cell adhesion. Cell 1992; 69: 11-25.
7. Takeichi M. Cadherin cell adhesion receptors as a morphogenic regulator. Science 1991; 251: 1451-5.
8. Williams AF, Barklay AN. The immunoglobulin superfamily domain for cell surface recognition. Ann Rev Immunol 1988; 6: 381-6.
9. Bevilaqua M, Butcher E, Furie B, Gallatin M, Gimbrone M, Harlan J, Kishimoto K, Lasky L, Mc Ever R. Selectins: a family of adhesion receptors. Cell 1991; 67: 233-41.
10. Aruffo A, Stamencovic I, Melnick M, Underhill CB, Seed B. CD 44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303-13.
11. Larson RS, Springer TA. Structure and function of leukocyte integrins. Immunol Rev 1990; 114: 181-217.
12. Haas TA, Plow EF. Integrin-ligand interactions: a year in review. Curr Opin Cell Biol 1994; 6: 656-62.
13. Van Waas C. Cell adhesion and regulatory molecules involved in tumor formation, hemostasis and wound healing. Head Neck 1995; 17: 140-7.
14. O'Toole TE, Katagiri Y, Faull RJ, Peter K, Tamura R, Quaranta V, Loftus JC, Shattil SJ, Ginsberg MH. Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol 1994; 124: 1047-57.
15. Elises MJ, Hemler ME. The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others. Proc Natl Acad Sci USA 1996; 86: 9906-10.
16. Languino LR, Gehlsen KR, Wayner E, Carter WF, Engvall E, Ruoslahti E. Endothelial cells use a2b1 integrin as a laminin receptor. J Cell Biol 1989; 109: 2455-62.
17. Ramroth H, Dietz A, Becher H. Interaction effects and population-attributable risks for smoking and alcohol on laryngeal cancer and its subsites. A case-control study from Germany. Methods Inf Med 2004; 43: 499-504.
18. Gallus S, Bosetti C, Franceschi S, Levi F, Negri E, La Vecchia C. Laryngeal cancer in women: tobacco, alcohol, nutritional, and hormonal factors. Cancer Epidemiol Biomarkers Prev 2003; 12: 514-7.
19. Amar A, Franzi SA, Rapoport A. Evolution of patients with squamous cell carcinoma of upper aerodigestive tract. Sao Paulo Med J 2003; 121: 155-8.
20. Haque MR, Abdullah M, Alauddin M, al-Haroon A, Majed MA, Ali MS. Carcinoma larynx-topographical distribution. Mymensingh Med J 2002; 11: 15-21.
21. Resta L, Piscitelli D, Fiore MG, Di Nicola V, Fiorella AM, Altavilla A, Marzullo A. Incidental metastases of well-differentiated thyroid carcinoma in lymph nodes of patients with squamous cell head and neck cancer: eight cases with a review of the literature. Eur Arch Otorhinolaryngol 2004; 261: 473-8.
22. Marchisio PC, Bondanza S, Gremona O, Cancedda R, De Luca M. Polarized expression of integrin receptors (a6b4, a2b1, a3b1, anb5) and their relationship with the cytoskeleton and basement membrane matrix in cultured human ceratinocytes. J Cell Biol 1991; 112: 761-73.
23. Stepp MA, Spurr M, Tisdale A, Elwell S, Gipson IK. a6b4 integrin heterodimer is a component of hemidesmosomes. Proc Natl Acad Sci USA 1990; 87: 8970-4.
24. Ricci E, Cavalot L, Sanvito F, Bussi M, Albera R, Staffieri A, Cortesina G, Marchisio PC. Differential expression and topography of adhesion molecules in laryngeal and otopharyngeal carcinomas. Acta Otolaryngol 2002; 122: 234-40.
25. Spinardi L, Ren YN, Sanders R, Giancotti FG. The b4 subunit cytoplasmic domain mediates the interaction of a6b4 integrin with the cytoskeleton of hemidesmosomes. Mol Biol Cell 1993; 4: 871-84.
26. Savoia P, Trusolino L, Pepino E, Cremona O, Marchisio PC. Expression and topography of integrins and basement membrane proteins in epidermal carcinomas: basal but not squamous cell carcinomas display loss of a4b6 and BM-600/NICEIN. J Invest Dermatol 1993; 101: 352-8.
27. Ryan MC, Tizad R, Vandevanter DR, Carter WG. Cloning of lam A3 gene encode the a3 chain of the adhesive ligand epiligrin. Expression in wound repair. J Biol Chem 1994; 269: 22779-87.
28. Juliano RL, Varner IA. Adhesion molecules in cancer: the role of integrins. Curr Opin Cell Biol 1993; 5: 812-8.
29. Cortesina G, Buss M, Carvelato MT, Ferro S, Panizzut B, Cavalot L, Gervasio CF, Marchisio PC. Significance of adhesion molecules as biological prognostic factor in locally advanced laryngeal squamous cell carcinomas. Acta Otolaryngol (Stockh) 1996; 116: 350-2.
30. Van Waes C, Carey TE. Overexpression of A9 antigen/a6b4 integrin in head and neck cancer. In: Otolaryngol Clinics of North America. Grundfast KM, ed. Philadelphia: WB Saouders, 1992; 1117.
31. Van Waes C, Kozarsky KF, Warren AB, Kidd L, Paugh D, Liebert M, Carey TE. The A9 antigen associated with aggressive human squamous carcinoma is structurally and functionally similar to the newly defined integrin a6b4. Cancer Res 1991; 51: 2395-402.
32. Wolf GT, Carey TE, Schmaltz SP, Mc Clachey KD, Poore J, Hayashida DJ, Hsu S. Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck. J Natl Cancer Inst 1990; 2: 1566-72.
33. Zambruno G, Marchisio PC, Markoni A, Vaschieric C, Melchiori A, De Luca M. Transforming growth factor-b1 modulates b1 and b5 integrins receptors and induces the de novo expression of the anb6 heterodimer in normal human keratinocytes implications for in vivo wound healing. J Cell Biol 1995; 129: 853-65.
34. Carvelato MT, Trusolino L, Serini G, Valente G, Orlandif Angeli A, Cortesina G, Marchisio PC. Differential integrin expression in thyroid and laryngeal carcinomas. Anticancer Res 1996; 16: 2379-84.
35. Borsi L, Carnemolla P, Spina B, Tanara G, Zardi L. Expression of different tenascin isoforms in normal, hyperplastic and neoplastic breast tissues. Int J Cancer 1987; 52: 688-92.
36. Vitolo D, Ciocci L, Ferrauti P, Cicerone E, Gallo A, De Vincentiis M, Baroni CD. a5 integrin distribution and TGFb1 gene expression in supraglottic carcinoma: their role in neoplastic local invasion and metastasis. Head Neck 2000; 22: 48-56.
37. Pyke C, Salo S, Ralf Kiaer E, Romer S, Dano K, Trygevason K. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is co-expressed with the receptor for urokinase plasminogen activator in colon adenocarcinomas. Cancer Res 1995; 55: 4132-9.
38. Brooks PC, Clark RAF, Cheresh DA. Requirement of vascular integrin anb3 for angiogenesis. Science 1994; 264: 569-71.
39. Chen YQ, Duniec ZM, Liu B, Hagman W, Gao X, Shimoji K, Marnett LJ, Jhonson CR, Honn KV. Endogenous 12(s)-HETE production by tumor cells and its role in metastasis. Cancer Res 1994; 54: 1574-9.
40. Chopa H, Timar J, Chen YQ, Rong XG, Grossi IM, Fitzgerald LA, Taylor JD, Honn KV. The lipooxygenase metabolite 12(s)-HETE induces a cytoskeleton- dependent increase in surface expression of integrin aIIbb3 on melanoma cells. Int J Cancer 1991; 49: 774-86.
41. Aumailley M, Rousselle P. Laminins of the dermo-epidermal junction. Matrix Biol 1999; 18: 19-28.
42. Nordemar S, Kronenwett U, Auer G, Hogmo A, Lindholm J, Edstrom S, Trygvasson K, Linder S, Munk-Wikland E. Laminin-5 as a predictor of invasiveness in cancer in situ lesions of the larynx. Anticancer Res 2001; 21: 509-12.
43. Wewer UM, Taraboleti G, Sobel ME, Albrechtsen R, Liotta LA. Role of laminin receptor in tumor cell migration. Cancer Res 1987; 47: 5691-8.
44. Carnemola B, Borsi L, Zardi L, Owens RJ, Baralle FE. Localization of the cellular fibronectin-specific epitope recognized by the monoclonal antibody IST-9 using fusion proteins expressed in E.coli. FEBS Lett 1987; 215: 265-73.
45. Fausto N. Multifunctional roles of transforming growth factor b1 Lab Invest 1991; 65: 497-9.
46. th Ann Meeting Am Ass Cancer Res April 12-16, San Diego CA 1997; 38: 389.